W Piehlmeier

454 total citations
21 papers, 324 citations indexed

About

W Piehlmeier is a scholar working on Endocrinology, Diabetes and Metabolism, Transplantation and Nephrology. According to data from OpenAlex, W Piehlmeier has authored 21 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Transplantation and 4 papers in Nephrology. Recurrent topics in W Piehlmeier's work include Renal Transplantation Outcomes and Treatments (5 papers), Diabetes Management and Research (4 papers) and Diabetes Management and Education (3 papers). W Piehlmeier is often cited by papers focused on Renal Transplantation Outcomes and Treatments (5 papers), Diabetes Management and Research (4 papers) and Diabetes Management and Education (3 papers). W Piehlmeier collaborates with scholars based in Germany, United Kingdom and Switzerland. W Piehlmeier's co-authors include W. Land, Monika Bullinger, R. Landgraf, R Landgraf, Eva M. Kohner, S J Aldington, Massimo Porta, Toke Bek, Hylton R. Mayer and K.D. Hepp and has published in prestigious journals such as Diabetes Care, Diabetologia and Diabetic Medicine.

In The Last Decade

W Piehlmeier

21 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W Piehlmeier Germany 9 113 112 93 64 48 21 324
M Grüsser Germany 6 57 0.5× 42 0.4× 137 1.5× 23 0.4× 10 250
Shirley Rosen Israel 12 224 2.0× 206 1.8× 27 0.3× 56 0.9× 19 412
Asma Maqsood Pakistan 6 30 0.3× 26 0.2× 208 2.2× 36 0.6× 11 333
Shehla Baqai Pakistan 5 27 0.2× 28 0.3× 241 2.6× 29 0.5× 32 365
P H Scanlon United Kingdom 12 530 4.7× 487 4.3× 90 1.0× 10 0.2× 1 0.0× 23 626
Enrico Bernardi Italy 9 24 0.2× 17 0.2× 6 0.1× 140 2.2× 14 0.3× 28 261
Raviv Allon Israel 10 66 0.6× 53 0.5× 7 0.1× 85 1.3× 33 261
Ranjana Sharma India 10 45 0.4× 33 0.3× 7 0.1× 29 0.5× 61 221
S T D Roxburgh United Kingdom 7 200 1.8× 98 0.9× 12 0.1× 7 0.1× 1 0.0× 16 281
Woon Cho Kim United States 8 88 0.8× 124 1.1× 34 0.4× 17 0.3× 21 285

Countries citing papers authored by W Piehlmeier

Since Specialization
Citations

This map shows the geographic impact of W Piehlmeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W Piehlmeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W Piehlmeier more than expected).

Fields of papers citing papers by W Piehlmeier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W Piehlmeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W Piehlmeier. The network helps show where W Piehlmeier may publish in the future.

Co-authorship network of co-authors of W Piehlmeier

This figure shows the co-authorship network connecting the top 25 collaborators of W Piehlmeier. A scholar is included among the top collaborators of W Piehlmeier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W Piehlmeier. W Piehlmeier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hubertus, Jochen, W Piehlmeier, & Maria Heinrich. (2016). Communicating the Improvements Developed from Critical Incident Reports is an Essential Part of CIRS. Klinische Pädiatrie. 228(5). 270–274. 4 indexed citations
2.
Piehlmeier, W, et al.. (2009). Screening of diabetic patients for microalbuminuria in primary care — The PROSIT-Project. Experimental and Clinical Endocrinology & Diabetes. 107(4). 244–251. 4 indexed citations
3.
Happich, Michael, et al.. (2008). The economic burden of nephropathy in diabetic patients in Germany in 2002. Diabetes Research and Clinical Practice. 80(1). 34–39. 11 indexed citations
4.
Meisinger, Christa, Margit Heier, Rüdiger Landgraf, et al.. (2008). Albuminuria, cardiovascular risk factors and disease management in subjects with type 2 diabetes: a cross sectional study. BMC Health Services Research. 8(1). 226–226. 20 indexed citations
5.
Kuch, Bernhard, Wolfgang von Scheidt, Wolfgang Peter, et al.. (2007). Sex-Specific Determinants of Left Ventricular Mass in Pre-Diabetic and Type 2 Diabetic Subjects. Diabetes Care. 30(4). 946–952. 14 indexed citations
6.
Luzio, Stephen D., et al.. (2006). Results of the pilot study of DIADEM—A comprehensive disease management programme for type 2 diabetes. Diabetes Research and Clinical Practice. 76(3). 410–417. 10 indexed citations
7.
Piehlmeier, W, et al.. (2006). Ten years experience with the disease management programme PROSIT® for diabetes. Diabetes Research and Clinical Practice. 74. S205–S209. 4 indexed citations
8.
Piehlmeier, W, et al.. (2005). Blood flow in the skin of type 1 diabetic patients before and after combined pancreas/kidney transplantation. Diabetes/Metabolism Research and Reviews. 21(6). 525–532. 7 indexed citations
9.
Rupprecht, Harald & W Piehlmeier. (2005). [Recommendations for the management of diabetic patients with nephropathy].. PubMed. 147(21). 43–6. 4 indexed citations
10.
Luzio, Stephen D., W Piehlmeier, Susanne Eberl, et al.. (2005). DIADEM: implementation of a comprehensive disease management programme for type 2 diabetes. Practical Diabetes International. 22(3). 93–97. 4 indexed citations
11.
12.
Piehlmeier, W, R. Renner, W Schramm, et al.. (2001). PROSIT--a quality management system for diabetic patients with nephropathy in Germany.. PubMed. 14(2). 110–4. 2 indexed citations
13.
Palmer, Andrew, et al.. (2000). Erhöhter klinischer und wirtschaftlicher Nutzen durch PROSIT (Proteinurie Screening und Intervention) bei Typ 2 diabetischen Patienten. DMW - Deutsche Medizinische Wochenschrift. 125(39). 1154–1159. 14 indexed citations
14.
Kohner, Eva M., W Piehlmeier, S J Aldington, et al.. (2000). A telemedical approach to the screening of diabetic retinopathy: digital fundus photography.. Diabetes Care. 23(3). 345–348. 123 indexed citations
15.
Piehlmeier, W, et al.. (1998). Evaluation of the Micral-Test ® S, a qualitative immunologic patient self-test for microalbuminuria: the PROSIT project. Diabetic Medicine. 15(10). 883–885. 2 indexed citations
16.
Piehlmeier, W, Monika Bullinger, Inge Kirchberger, W. Land, & R Landgraf. (1996). Evaluation of the quality of life of patients with insulin-dependent diabetes mellitus before and after organ transplantation with the SF 36 health survey.. PubMed. 162(12). 933–40. 43 indexed citations
17.
Schneeberger, H., Gunther O. Hofmann, W Piehlmeier, et al.. (1995). Duct occlusion-induced vascularized islet grafts are not associated with progressive long-term dysfunction.. PubMed. 27(1). 1342–3. 1 indexed citations
18.
Piehlmeier, W, et al.. (1994). Prospective study of the quality of life in type I diabetic patients before and after organ transplantation.. PubMed. 26(2). 522–3. 7 indexed citations
19.
Piehlmeier, W, Monika Bullinger, J. Nusser, et al.. (1992). Quality of life in diabetic patients prior to or after pancreas transplantation in relation to organ function.. PubMed. 24(3). 871–3. 9 indexed citations
20.
Piehlmeier, W, Monika Bullinger, J. Nusser, et al.. (1991). Quality of life in Type 1 (insulin-dependent) diabetic patients prior to and after pancreas and kidney transplantation in relation to organ function. Diabetologia. 34(S1). S150–S157. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Grüsser Breakdown of academic impact, for papers by Shirley Rosen Breakdown of academic impact, for papers by Asma Maqsood Breakdown of academic impact, for papers by Shehla Baqai Breakdown of academic impact, for papers by P H Scanlon Breakdown of academic impact, for papers by Enrico Bernardi Breakdown of academic impact, for papers by Raviv Allon Breakdown of academic impact, for papers by Ranjana Sharma Breakdown of academic impact, for papers by S T D Roxburgh Breakdown of academic impact, for papers by Woon Cho Kim
Rankless by CCL
2026